Corporate
Description
  • Value proposition

    Our Vision : We have High Standards - We Build Companies - We have Impact

    Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).

    Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech

  • Original language

    Our Vision : We have High Standards - We Build Companies - We have Impact

    Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).

  • Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe

    Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe

  • https://www.kurmapartners.com/en
Entity interactions BETA
Entity TypeTweets Articles
baby vc baby vc
Venture Capital and Private Equity Principals
Other

25 Oct 2024


CSL CSL
Biotechnology Research
Other

3 Oct 2024


iii - financements iii - financements
Financial Services
Other

16 Sep 2024


UroMems UroMems
biotech, deeptech, healthtech
Other

28 Sep 2024


Paris Saclay Cancer Cluster (PSCC) Paris Saclay Cancer Cluster (PSCC)
deeptech, healthtech, Non-profit Organizations
Other

1 Oct 2024


PANTERA PANTERA
biotech, deeptech
Other

15 Sep 2024


SCK CEN SCK CEN
Research Services
Other

11 Sep 2024


EQT Life Sciences EQT Life Sciences
Venture Capital and Private Equity Principals
Other

16 Sep 2024


PMV PMV
Financial Services
Other

11 Sep 2024


IBA IBA
Medical Equipment Manufacturing
Other

11 Sep 2024


Radars
Loading...